Thomas P. Mathers's Net Worth
$12.8 Million
Who is Thomas P. Mathers?
Thomas P. Mathers has an estimated net worth of $12.8 Million. This is based on reported shares across multiple companies, which include CoLucid Pharmaceuticals, Inc., and Lifesci Acquisition II Corp..
SEC CIK
Thomas P. Mathers's CIK is 0001639978
Past Insider Trading and Trends
2016 was Thomas P. Mathers's most active year for acquiring shares with 10 total transactions. Thomas P. Mathers's most active month to acquire stocks was the month of April. 2016 was Thomas P. Mathers's most active year for disposing of shares, totalling 23 transactions. Thomas P. Mathers's most active month to dispose stocks was the month of August. 2015 saw Thomas P. Mathers paying a total of $53,274.75 for 908,770 shares, this is the most they've acquired in one year. In 2017 Thomas P. Mathers cashed out on 810,431 shares for a total of $33,327,498.95, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CoLucid Pharmaceuticals, Inc. No price found
Chief Executive OfficerThomas P. Mathers used to own units in Common Stock but no longer holds any shares there. In the year 2015 Thomas P. Mathers filed a total of 16 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -256.52K |
$46.50 | -$11,928,133.50 |
0
|
Mar 1
| |||
Form 4
| +0.89% | 2.25K |
$34.78 | -$52,237.95 | 256.52K |
Scheduled
|
Jan 5
| ||
Form 4
| +0.89% | 2.25K |
$38.75 | -$58,202.50 | 254.27K |
Scheduled
|
Dec 5
| ||
Form 4
| +0.91% | 2.25K |
$28.57 | -$42,916.95 | 248.92K |
Scheduled
|
Nov 5 - Nov 7
| ||
Form 4
| +0.92% | 2.25K |
$37.08 | -$55,694.16 | 246.67K |
Scheduled
|
Oct 5
| ||
Form 4
| -2.40% | -6.00K |
$23.32 | -$139,946.28 | 244.41K |
Scheduled
|
Sep 14
| ||
Form 4
| -1.08% | -2.75K |
$21.72 | -$141,212.02 | 250.41K |
Scheduled
|
Sep 5 - Sep 7
| ||
Form 4
| +0.90% | 2.25K |
$8.31 | -$12,481.62 | 253.16K |
Scheduled
|
Aug 5
| ||
Form 4
| +0.91% | 2.25K |
$9.73 | -$14,614.46 | 250.91K |
Scheduled
|
Jul 5
| ||
Form 4
| +0.91% | 2.25K |
$7.25 | -$10,883.94 | 248.65K |
Scheduled
|
Jun 5 - Jun 6
| ||
Form 4
| +14.43% | 30.44K |
$6.49 | -$94,909.76 | 241.4K |
May 5
| |||
Form 4
| +64.86% | 83K |
—
|
—
| 210.96K |
Mar 4
| |||
Form 4
| +1,606.13% | 120.46K |
$4.58 | -$273,856.52 | 127.96K |
Nov 5
| |||
Form 4
|
∞
| 7.5K |
$7.10 | $53,274.75 | 7.5K |
Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lifesci Acquisition II Corp. (SNCE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||